Back
Sherwin-Williams Vs. Janux Therapeutics Industry Stock Comparison
Buy
62
SHW
Sherwin-Williams
Last Price:
311.95
Seasonality Move:
2.72%
Sell
37
JANX
Janux Therapeutics
Last Price:
47.10
Seasonality Move:
8.69%
Buy
62
Sherwin-Williams (SHW)
is a Buy
Is Sherwin-Williams a Buy, Sell or Hold?
- The current Sherwin-Williams [SHW] share price is $314.02. The Score for SHW is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- SHW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.51. The Score for JANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SHW Stock Price Chart
What is Sherwin-Williams's stock price today?
-
The Sherwin-Williams share price today is $314.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHW is experiencing slight selling pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.51
The current trend is moderately bearish and JANX is experiencing slight buying pressure.
SHW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.88 | Sell |
| Relative Strength Index (14 RSI): | 47.77 | Sell |
| Chaikin Money Flow: | -514573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (304.74 - 317) | Buy |
| Bollinger Bands (100): | (302.87 - 332.01) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.15 | Buy |
| Relative Strength Index (14 RSI): | 44.86 | Sell |
| Chaikin Money Flow: | 80974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.11 - 57.95) | Sell |
| Bollinger Bands (100): | (11.92 - 49.08) | Buy |
SHW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 317.42 | Sell |
| 20-day SMA: | 310.59 | Buy |
| 50-day SMA: | 324.08 | Sell |
| 200-day SMA: | 291.8 | Buy |
| 8-day EMA: | 315.25 | Sell |
| 20-day EMA: | 314.75 | Sell |
| 50-day EMA: | 317.25 | Sell |
| 200-day EMA: | 296.49 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.33 | Sell |
| 20-day SMA: | 53.07 | Sell |
| 50-day SMA: | 45.84 | Buy |
| 200-day SMA: | 20 | Buy |
| 8-day EMA: | 50.58 | Sell |
| 20-day EMA: | 51.3 | Sell |
| 50-day EMA: | 44.97 | Buy |
| 200-day EMA: | 26.33 | Buy |
Sherwin-Williams Earnings Growth & SHW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.33 per share, an increase this year of $1.06 per share, and an increase next year of $1.33 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Sherwin-Williams Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||